Literature DB >> 12082609

p14(ARF) regulates E2F activity.

Sarah L Mason1, Oonagh Loughran, Nicholas B La Thangue.   

Abstract

The ARF protein product of the ink4a/arf locus is induced by a variety of oncogenic signals. ARF facilitates growth arrest through the p53 pathway by hindering the down-regulation of p53 activity mediated by MDM2, through the formation of a protein complex with MDM2. Here we have explored the possibility that human p14(ARF) activity is integrated with growth regulating pathways other than p53, and report our results that p14(ARF) can control the activity of the E2F transcription factor. p14(ARF) regulates E2F activity in different cell-types, including p53(-/-)/mdm(-/-) MEFs, thus excluding that the effects of p14(ARF) are indirectly caused through MDM2 modulation. p14(ARF) down-regulates E2F-dependent transcription, and in cells undergoing E2F-dependent apoptosis prompts cell cycle arrest. p14(ARF) possesses multiple binding domains for E2F-1, one of which resides within the N-terminal region and coincides with the regulation of E2F activity. A mutational analysis of p14(ARF) indicates that the E2F-1 and MDM2 binding domains can be distinguished. These results highlight the potential interplay between p14(ARF) and E2F, and establish p14(ARF) as a pleiotrophic regulator of cell growth that acts by targetting at least two key pathways in the control of proliferation, namely E2F and p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082609     DOI: 10.1038/sj.onc.1205524

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Authors:  Michael Novy; Regina Pohn; Peter Andorfer; Tina Novy-Weiland; Barbara Galos; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

4.  CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.

Authors:  Yihong Ma; Lu Chen; Gabriela M Wright; Smitha R Pillai; Srikumar P Chellappan; W Douglas Cress
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

5.  JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1.

Authors:  Mingli Yang; Song Wu; Jinghua Jia; W Stratford May
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 6.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

7.  Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.

Authors:  Sonia Rocha; Michelle D Garrett; Kirsteen J Campbell; Katie Schumm; Neil D Perkins
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

8.  Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1.

Authors:  Yoon-Jae Song; Mark F Stinski
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 9.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 10.  Melanomagenesis: overcoming the barrier of melanocyte senescence.

Authors:  Linan Ha; Glenn Merlino; Elena V Sviderskaya
Journal:  Cell Cycle       Date:  2008-04-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.